March 05, 2018
Safety Analysis of Leishmania Vaccine Used in a Randomized Canine Vaccine/Immunotherapy Trial
In Leishmania infantum–endemic countries, controlling infection within dogs, the domestic reservoir, is critical to public health. There is a need for safe vaccines that prevent canine progression with disease and transmission to others. Protective vaccination against Leishmania requires mounting a strong, inflammatory, Type 1 response. Three commercially available canine vaccines on the global veterinary market use saponin or inflammatory antigen components (Letifend) as a strong pro-inflammatory adjuvant. There is very little information detailing safety of saponin as an adjuvant in field trials. Safety analyses for the use of vaccine as an immunotherapeutic in asymptomatically infected animals are completely lacking. Leishmania infantum, the causative agent of canine leishmaniasis, is enzootic within U.S. hunting hounds. We assessed the safety of LeishTec® after use in dogs from two different clinical states: 1) without clinical signs and tested negative on polymerase chain reaction and serology or 2) without clinical signs and positive for at least one Leishmania diagnostic test. Vaccine safety was assessed after all three vaccinations to quantify the number and severity of adverse events. Vaccinated animals had an adverse event rate of 3.09%, whereas placebo animals had 0.68%. Receiving vaccine was correlated with the occurrence of mild, site-specific, reactions. Occurrence of severe adverse events was not associated with having received vaccine. Infected, asymptomatic animals did not have a higher rate of adverse events. Use of vaccination is, therefore, likely to be safe in infected, asymptomatic animals.
Read the full article in The American of Tropical Medicine and Hygiene.
More from CNAS
-
Colombia Tariffs, Banning Chinese Drones, and Stacie Pettyjohn on Drone Warfare
Podcast
Emily and Geoff play a quick round of Tariff Tarot to dissect Trump’s tariff threats on Colombia last weekend. Then they dig in to the bipartisan debate over banning various c...
By Emily Kilcrease, Stacie Pettyjohn & Geoffrey Gertz
-
Don’t Talk About the War
Commentary
Confronting aggressors and getting them to the negotiation table requires both carrots and sticks—in other words, diplomacy and military power....
By Franz-Stefan Gady
-
Sharper: Trump's First 100 Days
Commentary
Donald Trump takes office in a complex and volatile global environment. Rising tensions with China, the continued war in Ukraine, and instability in the Middle East all pose s...
By Charles Horn
-
Build a High-Low Mix to Enhance America’s Warfighting Edge and Deter China
Commentary
The Trump administration can take immediate actions to improve U.S. military capability, capacity, and warfighting to deter China and reverse negative trends in military power...
By Stacie Pettyjohn, Carlton Haelig, Becca Wasser & Josh Wallin
